Surgical | Ophthalmology Innovation Source

Mynosys

Zepto is an “innovative, disposable device for cataract surgery,” that uses precision-pulse technology to produce an “accurate and reproducible capsulotomy that is quick, safe, and very affordable,” Hendrick said. The Zepto is comprised of silicone, with a soft, clear suction cup—because of the material choice, surgeons have visibility through the cup. It also includes a…

Transcend Medical Ready To Make Move In MIGs

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 042″] Transcend Medical CMO Sean Ianchulev provides an update on COMPASS trial and shares company’s plan for the FDA. Podcast Guest Sean Ianchulev, MD, MPH Dr. Ianchulev is a physician-executive, innovator and venture capital investor with deep life-science and medical technology expertise. As an innovator he has been at the core…

Ophthalmology Lifetime Innovator Award

Presenter: William J. Link, PhD Bill was Founder, Chairman and CEO of Chiron Vision, sold in 1997. Bill founded and served as President of American Medical Optics (AMO), sold in 1986. View Full Profile Recipient: Richard Lindstrom, MD Dr Richard L Lindstrom, Founder and attending surgeon at Minnesota Eye Consultants, Adjunct Clinical Professor Emeritus at…

Plenary Talk: Valeant’s Approach to Innovation

Valeant Pharmaceuticals is undergoing increased scrutiny. A year ago, J. Michael Pearson, then president and CEO, laid out the company’s vision for developing new tools in ophthalmology. Presenter: J. Michael Pearson Mr. Pearson has been the CEO and serving on the Board since September 2010 and the Chairman of the Board since March 2011. View…

Alcon’s Plan For WaveTec’s ORA System

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 028″] Alcon’s Warner, Tom Frinzi Discuss the WaveTec Vision Acquisition Details. Podcast Guest Tom Frinzi Thomas Frinzi is Senior Vice President of Abbott’s vision business, which includes a broad ophthalmology portfolio across the areas of cataracts, refractive surgery (LASIK) and eye health products. Prior to joining Abbott, Mr. Frinzi held a…

WaveTec CEO Tom Frinzi Hints at Plans for Future

WaveTec CEO Tom Frinzi spoke to the ease of the deal that paired his company with Alcon, hints at plans for the future and explains how the Ophthalmology Innovation Summit aided the process of turning around the once troubled company. Speaking With: Tom Frinzi Thomas Frinzi is Senior Vice President of Abbott’s vision business, which…

Laurent Attias Explains How Alcon Will Maximize the Ora System’s Potential

Laurent Attias, head of Global Commercial Strategy of Alcon, explains why the WaveTec Vision integration has gone so well and how Alcon will maximize the Ora System’s potential. Also, Attias adds his insights on the fascinating joint venture between Alcon and Google to develop a next generation contact lens. Speaking With: Laurent Attias Laurent Attias…

CheckedUp

iDoc Inc. wants to revolutionize how doctors and patients interact. Its mobile platform allows doctors to educate patients, help them make decisions, and provide interactive tools for follow-up or chronic care. Founder and CEO Richard M. Awdeh, MD reported that in a recent clinical trial in four high-volume practices, CheckedUp reduced the share of patients…

Assort

Assort is a surgical management system that has insight, hindsight, and foresight, explained Assort Pty. Ltd.’s CEO Noel Alpins, MD. It can be used to analyze all ophthalmic parameters, including intraocular pressure and visual acuities. Assort uses the Alpins method to plan astigmatism surgery and analyze outcomes. Part of the Assort system, the iAssort software,…

FDA Q&A

Food and Drug Administration to adopt guidelines and standards to help expedite approvals. Two key players within the agency, Dr. Wiley Chambers and Dr. Malvina Eydelman, sat down for an open Q&A with Emmett Cunningham, MD, co-chair of OIS@AAO. Dr. Eydelman is director of the Division of Ophthalmic and Ear, Nose and Throat Devices, and…

IOPtima

Ronen Castro, CEO of Israeli company IOPtima Ltd., introduced the CLASS (CO2 Laser-Assisted Sclerectomy Surgery) procedure for glaucoma, which has results comparable to trabeculectomy, but is non-invasive. This was the company’s first year for commercial activity. In March it secured CFDA approval in China, and in the fourth quarter of this year it begins initial…

PowerVision

PowerVision Inc.’s FluidVision, an intraocular lens designed to treat presbyopia and/or cataracts, is the only technology that restores true accommodation, reported company President and CEO Barry Cheskin at the OIS forum. It does so by efficiently harnessing the natural muscular forces of accommodation in the eye to move fluids inside the lens. That fluid movement…